Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia

Journal of Clinical Virology

Volumn 58, Issue 2, 2013, Pages 443-448

  Plentz, Annelie ^a   Würdinger, Michael ^a   Kudlich, Matthias ^a   Modrow, Susanne ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Genotype; Parvovirus B19; Quantitative PCR; Seroprevalence; Transplantation

Indexed keywords

DNA; HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; FEMALE; GENOTYPE; GRAFT RECIPIENT; HEART GRAFT; HUMAN; HUMAN PARVOVIRUS B19; HUMAN PARVOVIRUS B19 INFECTION; KIDNEY GRAFT; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETICULOCYTE COUNT; RETROSPECTIVE STUDY; VIRUS GENOME; VIRUS INFECTION;

B19V; DEOXYRIBONUCLEIC ACID; DNA; F; FEMALE; GENOME EQUIVALENTS; GENOTYPE; GEQ; GT; HAEMOGLOBIN; HB; IGG; IGM; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTRAVENOUS IMMUNOGLOBULINS; IVIG; M; MALE, MEAN; PARVOVIRUS B19; QPCR; QUANTITATIVE PCR; QUANTITATIVE POLYMERASE CHAIN REACTION; RETI; RETICULOCYTES; SD; SEROPREVALENCE; STANDARD DEVIATION; TRANSPLANTATION; TX; Y; YEARS;

ADOLESCENT; ADULT; AGED; ANEMIA; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; TRANSPLANTATION; VIREMIA; YOUNG ADULT;

EID: 84884532025     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.07.007     Document Type: Article

References (27)

1. Corcioli F., Zakrzewska K., Rinieri A., Fanci R., Innocenti M., Civinini R., et al. Tissue persistence of parvovirus B19 genotypes in asymptomatic persons. J Med Virol 2008, 80:2005-2011.
2. Kuethe F., Lindner J., Matschke K., Wenzel J.J., Norja P., Ploetze K., et al. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Clin Infect Dis 2009, 49:1660-1666.
3. Schenk T., Enders M., Pollak S., Hahn R., Huzly D. High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy. J Clin Microbiol 2009, 47:106-110.
4. Eis-Hübinger A.M., Reber U., Abdul-Nour T., Glatzel U., Lauschke H., Pütz U. Evidence for persistence of parvovirus B19 DNA in livers of adults. J Med Virol 2001, 65:395-401.
5. Norja P., Hokynar K., Aaltonen L.M., Chen R., Ranki A., Partio E.K., et al. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA 2006, 103:7450-7453.
6. Tanawattanacharoen S., Falk R.J., Jennette J.C., Kopp J.B. Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis. Am J Kidney Dis 2000, 35:1166-1174.
7. Hokynar K., Brunstein J., Söderlund-Venermo M., Kiviluoto O., Partio E.K., Konttinen Y., et al. Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue. J Gen Virol 2000, 81:1017-1025.
8. Bonvicini F., La Placa M., Manaresi E., Gallinella G., Gentilomi G.A., Zerbini M., et al. Parvovirus B19 DNA is commonly harboured in human skin. Dermatology 2010, 220:138-142.
9. Söderlund-Venermo M., Hokynar K., Nieminen J., Rautakorpi H., Hedman K. Persistence of human parvovirus B19 in human tissues. Pathol Biol (Paris) 2002, 50:307-316.
10. Hokynar K., Norja P., Hedman K., Söderlund-Venermo M. Tissue persistence and prevalende of B19 virus types 1-3. Future Virol 2007, 2:377-388.
11. Plentz A., Hahn J., Holler E., Jilg W., Modrow S. Long-term parvovirus B19 viraemia associated with pure red cell aplasia after allogeneic bone marrow transplantation. J Clin Virol 2004, 31:16-19.
12. Liefeldt L., Plentz A., Klempa B., Kershaw O., Endres A.S., Raab U., et al. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. J Med Virol 2005, 75:161-169.
13. Knoester M., von dem Borne P.A., Vossen A.C., Kroes A.C., Claas E.C. Human parvovirus B19 genotype 3 associated with chronic anemia after stem cell transplantation, missed by routine PCR testing. J Clin Virol 2012, 54:368-370.
14. Knöll A., Louwen F., Kochanowski B., Plentz A., Stüssel J., Beckenlehner K., et al. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR). J Med Virol 2002, 67:259-266.
15. Plentz A., Jilg W., Kochanowski B., Ibach B., Knöll A. Detection of herpesvirus DNA in cerebrospinal fluid and correlation with clinical symptoms. Infection 2008, 36:158-162.
16. Cavallo R., Merlino C., Re D., Bollero C., Bergallo M., Lembo D., et al. B19 virus infection in renal transplant recipients. J Clin Virol 2003, 26:361-368.
17. Eid A.J., Brown R.A., Patel R., Razonable R.R. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis 2006, 43:40-48.
18. Park J.B., Kim D.J., Woo S.Y., Choi G.S., Chun J.M., Jung G.O., et al. Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients - a prospective study. Transpl Int 2009, 22:455-462.
19. Zolnourian Z.R., Curran M.D., Rima B.K., Coyle P.V., O'Neill H.J., Middleton D. Parvovirus B19 in kidney transplant patients. Transplantation 2000, 69:2198-2202.
20. Yango A., Morrissey P., Gohh R., Wahbeh A. Donor-transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunction. Transpl Infect Dis 2002, 4:163-166.
21. Liefeldt L., Buhl M., Schweickert B., Engelmann E., Sezer O., Laschinski P., et al. Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy. Nephrol Dial Transplant 2002, 17:1840-1842.
22. Carraturo A., Catalani V., Ottaviani D., Menichelli P., Rossini M., Terella D., et al. Parvovirus B19 infection and severe anemia in renal transplant recipients. Sci World J 2012, 2012. Article ID 102829.
23. Hübschen J.M., Mihneva Z., Mentis A.F., Schneider F., Aboudy Y., Grossman Z., et al. Phylogenetic analysis of human parvovirus b19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b. J Clin Microbiol 2009, 47:3735-3738.
24. Röhrer C., Gärtner B., Sauerbrei A., Böhm S., Hottenträger B., Raab U., et al. Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect 2008, 136:1564-1575.
25. Bredl S., Plentz A., Wenzel J.J., Pfister H., Möst J., Modrow S. False-negative serology in patients with acute parvovirus B19 infection. J Clin Virol 2011, 51:115-120.
26. Grabarczyk P., Kalińska A., Kara M., Wieczorek R., Ejduk A., Sulkowska E., et al. Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland. J Med Virol 2011, 83:142-149.
27. Gosset C., Viglietti D., Hue K., Antoine C., Glotz D., Pillebout E. How many times can parvovirus B19-related anemia recur in solid organ transplant recipients?. Transpl Infect Dis 2012, 14:E64-E70.